Efforts subsequently to sell the site came to nothing and the company’s directors decided to shutter the business in 2020. Manufacturing on the site stopped the previous year and the last of its staff were paid off in May 2021, leaving the Swiss drugs giant with just a sales presence in Ireland.
“The company is continuing with its plan to decommission and demolish its assets,” the directors state in accounts for Roche Ireland Limited for 2022, just filed with Companies Office. “It has successfully transitioned from a manufacturer to a construction site commencing the decontamination and demolition works in 2020, which will continue until 2026.”
Overall, the business reported a full year loss of €26.16 million in 2022, up on the €24.2 million recorded for 2021. The only income for the company was €1.07 million from the sale of scrap metal as the plant is taken apart. The company secured a new Environmental Protection Agency licence in February under which it will continue the work to return the site to brownfield status. It said there were no conditions in the licence that would result in significant additional material or financial commitments by Roche. There were no public objections to the licence, the company said.
The Clarecastle facility was initially established in 1974 as Syntex Ireland. It became part of Roche following the Swiss group’s $5.3 billion acquisition of Syntex in 1994.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: IrishTimesBiz - 🏆 6. / 77 Read more »
Source: businessposthq - 🏆 8. / 71 Read more »